Shingles vaccine trial for adults 40+
Treatments studied
Part of Infections clinical trials.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have not had shingles in the last 5 years.
- You have never received a shingles or chickenpox vaccine before.
- You are not pregnant or planning to become pregnant in the next 7 months.
- You do not have a weak immune system (such as from HIV, cancer treatment, or organ transplant).
- You have not used high-dose steroids for 2 weeks or more in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This study tests an investigational vaccine (SYS6017) to see how well it works and if it's safe for adults 40 and older. The vaccine aims to prevent shingles, a painful rash caused by the same virus as chickenpox.
This study tests a new vaccine to prevent shingles (a painful rash condition) in adults 50 and older. It checks how safe the vaccine is and how well it triggers the body's immune defense.
This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.
This trial tests a new investigational shingles vaccine to see if it is safe and produces an immune response in healthy adults 40 and older. Participating could help protect against shingles and its complications.
Hear when a new Vaccine-Preventable Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.